The Evolving Field of Stereotactic Body Radiation Therapy in Pancreatic Cancer
Pancreatic cancer remains a devastating disease with dismal outcomes despite the development of novel chemotherapeutic regimens and radiation techniques. Stereotactic body radiation therapy (SBRT) offers an advantage both in image guidance and radiation dose delivery to direct ablative doses to tumors with acceptable toxicity compared to conventional techniques. Recent literature is clustered with data pertaining to SBRT in patients with resectable, borderline resectable and locally advanced pancreatic tumors. We here present a summary of the current data and highlight the limitations and potential for future growth. Further clinical study in the form of multi-institutional trials is warranted to establish the role of SBRT in combination with new chemo- therapeutic agents as well as a non-invasive alternative to surgery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
---|---|
Enthalten in: |
Pancreas (Fairfax, Va.) - 3(2019), 1 vom: 30., Seite 9-14 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ghaly, Maged [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Revised 30.09.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.17140/POJ-3-110 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM305288229 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM305288229 | ||
003 | DE-627 | ||
005 | 20231225120841.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.17140/POJ-3-110 |2 doi | |
028 | 5 | 2 | |a pubmed24n1017.xml |
035 | |a (DE-627)NLM305288229 | ||
035 | |a (NLM)31930185 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ghaly, Maged |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Evolving Field of Stereotactic Body Radiation Therapy in Pancreatic Cancer |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.09.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Pancreatic cancer remains a devastating disease with dismal outcomes despite the development of novel chemotherapeutic regimens and radiation techniques. Stereotactic body radiation therapy (SBRT) offers an advantage both in image guidance and radiation dose delivery to direct ablative doses to tumors with acceptable toxicity compared to conventional techniques. Recent literature is clustered with data pertaining to SBRT in patients with resectable, borderline resectable and locally advanced pancreatic tumors. We here present a summary of the current data and highlight the limitations and potential for future growth. Further clinical study in the form of multi-institutional trials is warranted to establish the role of SBRT in combination with new chemo- therapeutic agents as well as a non-invasive alternative to surgery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Pancreas cancer | |
650 | 4 | |a Pancreatic neoplasms | |
650 | 4 | |a Radiation | |
650 | 4 | |a Radiosurgery | |
650 | 4 | |a Radiotherapy | |
650 | 4 | |a Stereotactic | |
650 | 4 | |a Stereotactic body radiation therapy (SBRT) | |
700 | 1 | |a Gogineni, Emile |e verfasserin |4 aut | |
700 | 1 | |a Saif, Muhammad W |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pancreas (Fairfax, Va.) |d 2019 |g 3(2019), 1 vom: 30., Seite 9-14 |w (DE-627)NLM305288210 |x 2471-142X |7 nnns |
773 | 1 | 8 | |g volume:3 |g year:2019 |g number:1 |g day:30 |g pages:9-14 |
856 | 4 | 0 | |u http://dx.doi.org/10.17140/POJ-3-110 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 3 |j 2019 |e 1 |b 30 |h 9-14 |